Showing results (31-40 of 115) with videos related to
Sort By:
Pageof 12
The Journal of Clinical Psychiatry|May 1, 1983
A multicenter evaluation of bupropion versus placebo in hospitalized depressed patientsL F Fabre, H K Brodie, D Garver, et al.Brain Research|June 1, 1981
Increased ouabain binding after repeated noradrenergic stimulationA C Swann, S J Grant, D Jablons, et al.Science (New York, N.Y.)|September 28, 1973
Behavior of free-ranging macaques after intraventricular 6-hydroxydopamineD E Redmond, R L Hinrichs, J W Maas, et al.Archives of General Psychiatry|June 1, 1988
Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquinJ W Maas, S A Contreras, E Seleshi, et al.Archives of General Psychiatry|November 1, 1978
Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal studyD Pickar, D R Sweeney, J W Maas, et al.Science (New York, N.Y.)|January 19, 1973
Urinary catecholamine metabolites during behavioral changes in a patient with manic-depressive cyclesF D Jones, J W Maas, H Dekirmenjian, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 30, 2013
Can the spread of agriculture in Europe be followed by tracing the spread of the weed Silene latifolia. A RAPD studyP Vellekoop, J B Buntjer, J W Maas, et al.Molecular Pharmacology|April 1, 1999
Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau protein at Thr181 and Thr231T D Garver, R L Kincaid, R A Conn, et al.Psychopharmacology|January 1, 1983
Comparative efficacy and safety of bupropion and placebo in the treatment of depressionW W Zung, H K Brodie, L Fabre, et al.Metabolic Brain Disease|September 1, 1987
Disposition of homovanillic acid in the primateA L Miller, R W Keenan, J W Maas, et al.Pageof 12